Aeroflow Health, a pioneering healthcare company that leverages cutting-edge technology to support the delivery of medical products and services, announced a new partnership with Molina Healthcare of ...
Novel oral GRK2-biased β2 adrenergic receptor agonists show potential for safer glucose management and obesity treatment.
High-deductible health insurance plans are increasingly common, and many more enrollees will likely need to choose such plans ...
Launch targets $16 billion SGLT-2 inhibitor market that serves 33 million type II diabetics in the US, many of whom are ...
The Yakima Free Clinic has had more than 800 patient visits since opening in May. Volunteers, donations and community ...
LAS CRUCES, NEW MEXICO / ACCESS Newswire / December 2, 2025 / Following CMS’s announcement of the new ACCESS Model (Advancing ...
Discover how Aga Khan University Hospital tackles doctor migration in Africa with competitive pay, world-class equipment, and ...
Asianet Newsable on MSN
Novo Nordisk launches diabetes drug Ozempic in India at Rs 2200/dose
Novo Nordisk has launched Ozempic (injectable semaglutide) in India for adults with uncontrolled type 2 diabetes. The ...
The Division of Continuing Professional Development (CPD) at Weill Cornell Medicine-Qatar (WCM-Q) recently hosted its third ...
People with Type 2 diabetes who combined healthy lifestyle habits with GLP-1 receptor agonist (GLP-1 RA) medications had a ...
For the fourth year in a row, UC San Diego Health is recognized as a Best Hospital for Maternity Care by U.S. News & World ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback